Oral delivery of insulin via mesoporous carbon nanoparticles for colonic release allows glycemic control in diabetic rats
Sign Up to like & getrecommendations! Published in 2019 at "Carbon Letters"
DOI: 10.1007/s42823-019-00033-z
Abstract: In this article, a new type of mesoporous carbon nanoparticles (MCN) was fabricated as a potential oral delivery system of insulin to reduce the adverse reactions by hypodermic injection. The mesoporous carbon nanoparticles-carried insulin (MCNI)… read more here.
Keywords: insulin; carbon; microscopy; carbon nanoparticles ... See more keywords
Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults.
Sign Up to like & getrecommendations! Published in 2018 at "Contributions to nephrology"
DOI: 10.1159/000486930
Abstract: Minimal change nephrotic syndrome (MCNS) usually responds to steroids but frequently relapses, requiring additional treatment with immunosuppressive agents. Rituximab is a chimeric murine/human monoclonal immunoglobulin G1 antibody that targets CD20, a B-cell differentiation marker. B-cell… read more here.
Keywords: change nephrotic; mcns; minimal change; nephrotic syndrome ... See more keywords